This topic contains a solution. Click here to go to the answer

Author Question: The deadweight loss represents the sum of additional consumer and producer surplus should the firm ... (Read 69 times)

bio_gurl

  • Hero Member
  • *****
  • Posts: 524
The deadweight loss represents the sum of additional consumer and producer surplus should the firm produce the quantity where P = MC rather than where MR = MC.
 
  Indicate whether the statement is true or false

Question 2

If a competitive firm is in short-run equilibrium, then
 
  A) profits equal zero.
  B) it will not operate at a loss.
  C) an increase in its fixed cost will have no effect on profit.
  D) an increase in its fixed cost will have no effect on output.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

triiciiaa

  • Sr. Member
  • ****
  • Posts: 349
Answer to Question 1

True . If P = MC is produced, quantity increases, and the deadweight loss is turned into more CS and PS. This will increase total welfare.

Answer to Question 2

D




bio_gurl

  • Member
  • Posts: 524
Reply 2 on: Jul 1, 2018
Thanks for the timely response, appreciate it


T4T

  • Member
  • Posts: 348
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library